Search

everythinglearnresearchcommunity

for

Search:↓

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

Minoxidil-loaded liposomes effectively deliver to hair follicles, potentially improving hair growth and treating alopecia.

Targeting the skin's endocannabinoid system could help treat skin disorders.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

New drug delivery methods can make natural compounds more effective and stable.

M30 is a promising treatment for preventing hair loss during chemotherapy.

A blood pressure drug, diltiazem, may also help treat influenza.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Chitosan nanoparticles improve minoxidil delivery to hair follicles for better alopecia treatment.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Stem cells and their exosomes show promise for repairing tissues and healing wounds when delivered effectively, but more research is needed on their tracking and optimal use.

New method improves copper peptide delivery for hair growth three times better than current options.

Natural compounds from Chinese herbs may safely promote hair growth and treat common hair loss.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.